Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07453550 · ClinicalTrials.gov registry record · NA
The Effects of Brief Periods of Exercise on Blood Pressure
A NA study, sponsored by University of Hartford.
- Recruiting
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT07453550: Recruiting NA study, sponsored by University of Hartford.
NCT07453550 is a NA study that is actively recruiting participants, run by University of Hartford. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07453550, a NA study, is actively recruiting participants, sponsored by University of Hartford.
- RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
High blood pressure is a common medical condition that affects the body's arteries. It's also called hypertension. Untreated hypertension increases the risk of heart attack, stroke and other serious health problems. Exercise is a promising tool in hypertension management. Regular participation in exercise improves vascular health, heart and lung function, and multisystem health. However, the direct evidence of the treatment effects of a brief period of exercise on blood pressure in individuals with hypertension is limited. A brief period of exercise refers to an exercise protocol that only lasts for a very short period of time, such as 5-10 minutes.
Primary Outcome
The average, peak and variations of 24 h SBP and DBP, daytime SBP and DBP, night time SBP and DBP will be measured before and after the intervention.
Interventions
- BEHAVIORAL wall-squat
- BEHAVIORAL wall-squat-tradition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2026-02-01 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT07453550 shows while recruiting
NCT07453550 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which wall-squat is the first listed.
NCT07453550 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07453550 about?
NCT07453550 is a clinical study titled "The Effects of Brief Periods of Exercise on Blood Pressure". High blood pressure is a common medical condition that affects the body's arteries. It's also called hypertension. Untreated hypertension increases the risk of heart attack, stroke and other serious health problems. Exercise is a promising tool in hypertension management. Regular participation in ex...
What is the current status of trial NCT07453550?
This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2026-02-01. Estimated completion is 2027-06.
What interventions are being tested in trial NCT07453550?
The interventions under investigation include: wall-squat (BEHAVIORAL), wall-squat-tradition (BEHAVIORAL).
Who is sponsoring clinical trial NCT07453550?
This trial is sponsored by University of Hartford, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07453550's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI